Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-7601
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany ; volume:16 ; number:5 ; day:25 ; month:5 ; year:2014 ; pages:471-488 ; date:6.2015
The European journal of health economics ; 16, Heft 5 (25.5.2014), 471-488, 6.2015
- Creator
-
Damm, Oliver
Eichner, Martin
Rose, Markus Andreas
Knuf, Markus
Wutzler, Peter
Liese, Johannes Günter
Krüger, Hagen
Greiner, Wolfgang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10198-014-0586-4
- URN
-
urn:nbn:de:101:1-2019102818185899355444
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Damm, Oliver
- Eichner, Martin
- Rose, Markus Andreas
- Knuf, Markus
- Wutzler, Peter
- Liese, Johannes Günter
- Krüger, Hagen
- Greiner, Wolfgang
- SpringerLink (Online service)
Other Objects (12)
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Influenza vaccination in pediatric age
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
Influenza vaccination in pediatric age
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness
Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy
Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses